Contact Us
Registration Questions?
Send Email
1.888.257.6457
+1.215.442.6100
Agenda Details and Event Logistics
Where Life Science Leaders Solve What's Next
From AI in drug development to the latest advances across therapeutic areas, DIA 2026 brings together 4,000+ professionals from industry, regulatory agencies, and patient advocacy to tackle the challenges reshaping healthcare right now.
Register NowYou'll Be in Good Company
We believe in the power of collaboration to advance global health and empower professionals to deliver trusted and productive solutions for patients.
We also believe in continuous evolution—bringing together diverse perspectives, cutting-edge science, and regulatory expertise to accelerate therapeutic development.
We're committed to helping our community drive healthcare innovation faster by connecting the right people at the right time.
DIA 2026 Highlights
Breaking Down Silos
Connect with stakeholders across industry, regulatory agencies, academia, and patient advocacy to tackle complex challenges together. DIA provides the neutral ground where different perspectives converge to drive innovation.
View AgendaInternational Impact
With participants from over 50 countries, gain unparalleled access to international regulatory harmonization discussions, global market strategies, and cross-border collaboration opportunities that impact worldwide product development.
Explore Our OfferingsThe Evolution of DIA
From a small meeting of industry professionals to the premier global gathering for life sciences innovation
2026 Meets America's 250th Anniversary
As Philadelphia celebrates America's Semiquincentennial—250 years since the signing of the Declaration of Independence—DIA returns to this historic city where innovation, collaboration, and bold ideas have always flourished. Just as America's founders gathered here to shape a new nation, today's life sciences leaders convene to shape the future of global health.
Learn More About PhiladelphiaDIA Is Founded
DIA was founded by 30 pharmaceutical professionals, medical writers, and academics after they saw the Thalidomide issue as a global epidemic and saw the need for an organization that could foster cooperative efforts across the world.
Global Expansion
DIA enters a period of global growth and expansion to support ICH and the scientific evaluation of medicines efforts, establishing formal offices in the US, Switzerland, and Japan. DIA members form a Community to define global data standards used in medical research, which leads to the formation of the Clinical Data Interchange Standards Consortium (CDISC).
Global Membership Growth
DIA membership expands globally to over 80 countries, with local offerings to Latin America, Canada, Korea, China, India, the Middle East and Singapore. DIA relaunches Drug Information Journal as Therapeutic Innovation & Regulatory Science.
DIA Reimagined for the Future
DIA 2026 represents the next evolution—enhanced learning formats, expanded networking, and innovative programming like the LIFT Series, while maintaining the power of in-person connection.